in Newswire November 15, 2019

Two Women File Class Action After Study Exposes Ineffectiveness of Preterm Birth Drug Makena

by Erin Gilmore

Last Updated on November 15, 2019

Faughnan et al. v. AMAG, Inc.

Filed: November 12, 2019 § 3:19-cv-01394

A lawsuit filed against Makena manufacturer AMAG, Inc. claims the “exorbitantly-priced” preterm birth medication is “no more effective than a placebo.”

Defendant(s)

AMAG, Inc.

Law(s)

State(s)

New York

Last Updated on November 15, 2019 — 4:11 PM

Erin Gilmore

erin@classaction.org

Erin works primarily on ClassAction.org’s newswire, reporting on cases as they happen.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.